Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab—a review
R King, N Tanna, V Patel - Oral surgery, oral medicine, oral pathology and …, 2019 - Elsevier
The link between medication-related osteonecrosis of the jaw (MRONJ) and bone
modulating drugs, such as bisphosphonates and denosumab, is well established, and the
number of reported cases is increasing. The development of novel medications used in the
treatment of cancer, as well as autoimmune and bone conditions, has led to more cases of
MRONJ being reported. However, in addition to this group of medications, increasing
numbers of new agents in cancer therapy, such as antiangiogenic agents, have also been …
modulating drugs, such as bisphosphonates and denosumab, is well established, and the
number of reported cases is increasing. The development of novel medications used in the
treatment of cancer, as well as autoimmune and bone conditions, has led to more cases of
MRONJ being reported. However, in addition to this group of medications, increasing
numbers of new agents in cancer therapy, such as antiangiogenic agents, have also been …
